Phase I/II clinical trial of HLA-A24 restricted epitope peptide cocktail therapy with UFT+LV for patients with advanced metastatic colorectal cancer.
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2623214
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Subcutaneous injection of cancer vaccine (seven peptides) UFT+LV
Primary outcome(s): Safty Immunological response (in vitro CTL induction)
Study Design: Single arm Non-randomized
创建时间：
2011-09-15
